Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and Above

Clinical trial NCT05720455 · COMPLETED

Trial details

NCT number: NCT05720455
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rhinitis Allergic

Start date: 2025-06-15
Primary completion: 2025-12-05
Enrollment: 203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.